TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23097067

Group type: EXPERIMENTAL
Intervention: Sildenafil (target dose 40 mg three times per day)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 24482850

Group type: EXPERIMENTAL
Intervention: Visiting service
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 216
Study: 18580411

Group type: EXPERIMENTAL
Intervention: Contrast bathing (CB)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Compression garments (CG)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 26
Study: 16507180

Group type: EXPERIMENTAL
Intervention: Lateral position with operative side down (Group 1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sitting position then turned to lateral side (Group 2)
Number of subjects: 80
Study: 12741874

Group type: EXPERIMENTAL
Intervention: Active recovery (slow self-paced jogging)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Passive recovery (standing still)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Long line version
Number of subjects: 14

Group type: COMPARATOR
Intervention: Short line version
Number of subjects: 14
Study: 10757621

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion (50 pmol/kg x h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 20
Study: 8818093

Group type: EXPERIMENTAL
Intervention: Tea (150 ml)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Apple juice (150 ml)
Number of subjects: 40
Study: 1446762

Group type: EXPERIMENTAL
Intervention: Hyaluronidase (50 i.u./ml) and adrenaline (1:200,000)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Hyaluronidase alone
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Adrenaline alone
Number of subjects: 91

Group type: COMPARATOR
Intervention: Neither hyaluronidase nor adrenaline
Number of subjects: 91
Study: 31086379

Group type: EXPERIMENTAL
Intervention: Multimodal intervention 'Clean Hands, Happy Life' including HH products, reminders, training programs, and a kick-off event.
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Multimodal intervention 'Clean Hands, Happy Life'.
Number of subjects: 176
Study: 27364689

Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 120

Group type: COMPARATOR
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Swaddling
Number of subjects: 120
Study: 25881813

Group type: EXPERIMENTAL
Intervention: Routine methods plus dietary sweet potato consumption (200 g/d from admission to discharge)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine nursing methods
Number of subjects: 120
Study: 24902735

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Counselling
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 52
Study: 21978572

Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg
Number of subjects: 3117

Group type: EXPERIMENTAL
Intervention: Ustekinumab 90 mg
Number of subjects: 3117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3117
Study: 20958888

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 156
Study: 17383174

Group type: EXPERIMENTAL
Intervention: Topical vitamin E (800 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 15665146

Group type: EXPERIMENTAL
Intervention: Patients with histories of syncope
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 14
Study: 12413315

Group type: EXPERIMENTAL
Intervention: Laparoscopic repair
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional repair
Number of subjects: 22
Study: 10607223

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha)
Number of subjects: 24
Study: 7852539

Group type: EXPERIMENTAL
Intervention: Benfluorex (150 mg) three times daily for 6 weeks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 2182170

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Penicillamine
Number of subjects: 43

Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 43
Study: 7005122

Group type: EXPERIMENTAL
Intervention: 100 mg atenolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 200 mg atenolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 28315910

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (300μg orally for 10 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 16
Study: 26712981

Group type: EXPERIMENTAL
Intervention: IV clonidine 4 µg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: IV clonidine 5 µg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: IV clonidine 3 µg/kg
Number of subjects: 90
Study: 23736524

Group type: EXPERIMENTAL
Intervention: Vibration of the palmar surface of the hand
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vibration of the forearm applied over the flexor muscles
Number of subjects: 12

Group type: COMPARATOR
Intervention: No vibration
Number of subjects: 12
Study: 22338149

Group type: EXPERIMENTAL
Intervention: 100 mg rituximab weekly for 4 weeks (group A)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 375 mg/m2 rituximab single dose (group B)
Number of subjects: 51
Study: 19662727

Group type: EXPERIMENTAL
Intervention: ProTaper canal preparation and single cone obturation with matching gutta‐percha point
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: ProTaper preparation plus thermoplastic obturation (Thermafil)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Profile .06 taper and matching master cone with lateral condensation
Number of subjects: 42
Study: 17931541

Group type: EXPERIMENTAL
Intervention: Preprinted medication labels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blank medication labels
Number of subjects: 0
Study: 15355745

Group type: EXPERIMENTAL
Intervention: Targeting cytokines (IL-6, IL-12, IL-15, IL-18)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tumor necrosis factor blocking agents
Number of subjects: 0
Study: 11317091

Group type: EXPERIMENTAL
Intervention: Educational program for physicians emphasizing avoidance of NSAIDs, including face-to-face visits and reminder placements in patient charts.
Number of subjects: 1566

Group type: COMPARATOR
Intervention: Control group (no educational intervention).
Number of subjects: 1566
Study: 9121953

Group type: EXPERIMENTAL
Intervention: Coordinated Atrial Contraction (AC) during exercise in VVIR mode
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Coordinated Atrial Contraction (AC) during exercise in VVI mode
Number of subjects: 12

Group type: COMPARATOR
Intervention: Chronic Atrial Fibrillation (AF) during exercise in VVIR mode
Number of subjects: 12

Group type: COMPARATOR
Intervention: Chronic Atrial Fibrillation (AF) during exercise in VVI mode
Number of subjects: 12

Group type: COMPARATOR
Intervention: Resting levels in Chronic Atrial Fibrillation (AF)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Resting levels in Coordinated Atrial Contraction (AC)
Number of subjects: 12
Study: 8033771

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hydroflumethiazide
Number of subjects: 60
Study: 3322537

Group type: EXPERIMENTAL
Intervention: 6-hydroxybenzo[b]thiophene-2-sulfonamide, 2% suspension, administered twice daily for 1 week to one eye
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo drop, administered twice daily for 1 week to one eye
Number of subjects: 20
Study: 30087002

Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6MWT)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Hospital Anxiety and Depression Scale
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Montreal Cognitive Assessment
Number of subjects: 96
Study: 28635980

Group type: EXPERIMENTAL
Intervention: Multimodality educational intervention (video, PowerPoint slides, medical illustrations)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Multimodality educational intervention
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 8
Study: 25729161

Group type: EXPERIMENTAL
Intervention: Phasic electrical stimulation during expiration (PESE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 23307806

Group type: EXPERIMENTAL
Intervention: Flinders Program plus usual care
Number of subjects: 77

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 77
Study: 22014807

Group type: EXPERIMENTAL
Intervention: Toremifene 80 mg by mouth daily
Number of subjects: 847

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 847
Study: 19151449

Group type: EXPERIMENTAL
Intervention: Curcumin low dose (3 times 15 mg/day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Curcumin moderate dose (3 times 30 mg/day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Curcumin high dose (3 times 60 mg/day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Curcumin (all doses)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 75
Study: 16531903

Group type: EXPERIMENTAL
Intervention: 2.5 mg.kg(‐1) bw pseudoephedrine
Number of subjects: 7

Group type: COMPARATOR
Intervention: 2.5 mg.kg(‐1) bw maltodextrins (placebo)
Number of subjects: 7
Study: 14625607

Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection (PEI)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Percutaneous hydrochloric acid injection (PHI)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Needle aspiration only
Number of subjects: 27
Study: 11084175

Group type: EXPERIMENTAL
Intervention: Continuous regimen of oral conjugated equine estrogens (CEE), 0.625 mg/day, combined with medroxyprogesterone acetate (MPA), 5.0 mg/day
Number of subjects: 1724

Group type: COMPARATOR
Intervention: Continuous regimen of oral conjugated equine estrogens (CEE), 0.625 mg/day, combined with medroxyprogesterone acetate (MPA), 2.5 mg/day
Number of subjects: 1724
Study: 9065552

Group type: EXPERIMENTAL
Intervention: Intraepidermal nerve fiber (IENF) density measurement in patients with painful sensory neuropathies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intraepidermal nerve fiber (IENF) density measurement in control subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation of IENF density with clinical estimates of neuropathy severity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IENF density measurement at the calf
Number of subjects: 0
Study: 8445814

Group type: EXPERIMENTAL
Intervention: Smoking cessation (quitters)
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Smoking reduction (reducers)
Number of subjects: 803

Group type: COMPARATOR
Intervention: No change in smoking behavior (no changers)
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Smoking reduction
Number of subjects: 803
Study: 3554991

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 31047790

Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: PT followed by an increased dose of PT (PT-PT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: CBT followed by an increased dose of CBT (CBT-CBT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: PT followed by CBT (PT-CBT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: CBT followed by PT (CBT-PT)
Number of subjects: 99
Study: 28643374

Group type: EXPERIMENTAL
Intervention: LY2510924 (20 mg once daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LY2510924 (subcutaneous administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LY2510924
Number of subjects: 0
Study: 26407017

Group type: EXPERIMENTAL
Intervention: 23 G needle
Number of subjects: 200

Group type: COMPARATOR
Intervention: 25 G needle
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Anxiety prior to arterial puncture
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Pain experienced during arterial puncture
Number of subjects: 200
Study: 22951158

Group type: EXPERIMENTAL
Intervention: blood‐based crisp bread (35 mg of iron, 27 mg heme Fe)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: iron supplementation (35 mg of non‐heme iron/day)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: iron supplementation (60 mg of non‐heme iron/day)
Number of subjects: 77

Group type: COMPARATOR
Intervention: control (iron‐free tablets)
Number of subjects: 77
Study: 21272186

Group type: EXPERIMENTAL
Intervention: Insulin + pioglitazone 45 mg (n = 12)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Insulin therapy alone (n = 13)
Number of subjects: 25
Study: 19039237

Group type: EXPERIMENTAL
Intervention: Low-dose GH for 2 years (0.033/0.033 mg/kg/day, n = 51)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: High-dose GH for 1 year and then no treatment for 1 year (0.100/0 mg/kg/day, n = 51)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Mid-dose GH for 1 year (0/0.067 mg/kg/day, n = 47)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (untreated for 1 year)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Comparison of high-dose and low-dose GH after 2 years
Number of subjects: 151
Study: 17697905

Group type: EXPERIMENTAL
Intervention: SKI306X 200 mg TID
Number of subjects: 183

Group type: COMPARATOR
Intervention: Celecoxib 200 mg BID
Number of subjects: 183
Study: 15179169

Group type: EXPERIMENTAL
Intervention: Continuous training (CONT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Interval training (INT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 11986726

Group type: EXPERIMENTAL
Intervention: New inactivated HAV vaccine (1000 units)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Havrix (720 ELISA units)
Number of subjects: 31
Study: 9803693

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral program delivered on a weekend for groups of 4 couples
Number of subjects: 67

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral program
Number of subjects: 67
Study: 7702198

Group type: EXPERIMENTAL
Intervention: Celiprolol (200 mg/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Propranolol (80 mg/day)
Number of subjects: 53
Study: 2644795

Group type: EXPERIMENTAL
Intervention: Intravenous propafenone, 2 mg/kg over 10 minutes
Number of subjects: 15
Study: 766062

Group type: EXPERIMENTAL
Intervention: Glucagon (2 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pro‐Banthine (45 mg)
Number of subjects: 0
Study: 31280348

Group type: EXPERIMENTAL
Intervention: High-dose bortezomib (1.6 mg/m2) with dexamethasone and cyclophosphamide
Number of subjects: 85

Group type: COMPARATOR
Intervention: Low-dose bortezomib (1.3 mg/m2) with dexamethasone and cyclophosphamide
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: High-dose bortezomib (1.6 mg/m2)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: High-dose bortezomib (1.6 mg/m2) and low-dose bortezomib (1.3 mg/m2)
Number of subjects: 85
Study: 28327447

Group type: EXPERIMENTAL
Intervention: Motivational Interview Group (MIG)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Conventional Intervention Group (CIG)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 83
Study: 25349943

Group type: EXPERIMENTAL
Intervention: Pelvic muscle exercises (PMEs) with instruction and feedback
Number of subjects: 250

Group type: COMPARATOR
Intervention: Prior instruction
Number of subjects: 250

Group type: COMPARATOR
Intervention: Prior feedback
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Instruction 'Squeeze the vaginal muscles you use to hold your urine'
Number of subjects: 250
Study: 22935739

Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training (AIT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training (AIT) with placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training (AIT) with caffeine (3 mg·kg(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Resting with caffeine (3 mg·kg(‐1))
Number of subjects: 12
Study: 21450707

Group type: EXPERIMENTAL
Intervention: Bilateral insertion of 0.20×15 mm Seirin needles to 12 mm depth at ST36, daily treatments of 30 s duration for three consecutive workdays
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 0
Study: 19661447

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR)
Number of subjects: 8
Study: 17900887

Group type: EXPERIMENTAL
Intervention: SFC (S 50 mcg/FP 250 mcg b.i.d.)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: S+FP (S 50 mcg b.i.d.+FP 250 mcg b.i.d.)
Number of subjects: 35

Group type: COMPARATOR
Intervention: S+FP
Number of subjects: 35

Group type: COMPARATOR
Intervention: SFC
Number of subjects: 35
Study: 15144296

Group type: EXPERIMENTAL
Intervention: Intrathecal diamorphine 300 microg
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 40
Study: 11985192

Group type: EXPERIMENTAL
Intervention: Fissure sealants with resin-modified glass ionomer - Vitremer (n=29)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Fluoride varnish - Duraphat (n=36)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Tooth brushing and 0.2% NaF weekly mouthwashes (Control group, n=33)
Number of subjects: 250
Study: 9377658

Group type: EXPERIMENTAL
Intervention: Leukotrienes B4 and C4 levels in cerebrospinal fluid (CSF) of patients with multiple sclerosis
Number of subjects: 47

Group type: COMPARATOR
Intervention: Leukotrienes B4 and C4 levels in patients with atherosclerotic dementia
Number of subjects: 47

Group type: COMPARATOR
Intervention: Leukotrienes B4 and C4 levels in patients with headache
Number of subjects: 47
Study: 8197861

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-coating
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cement fixation
Number of subjects: 0
Study: 3390674

Group type: EXPERIMENTAL
Intervention: Surgery to the communicating veins and elastic stockings
Number of subjects: 41

Group type: COMPARATOR
Intervention: Elastic stockings only
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Surgery and elastic stockings in limbs without post-thrombotic changes
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Surgery and elastic stockings in limbs with post-thrombotic changes
Number of subjects: 41
Study: 29926752

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 31072314

Group type: EXPERIMENTAL
Intervention: Kypho-IORT (Kyphoplasty plus IORT with 8 Gy prescribed to 13 mm depth)
Number of subjects: 54

Group type: COMPARATOR
Intervention: EBRT (External Beam Radiotherapy) with either 30 Gy in 10 fractions or 8 Gy as a single dose
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Kypho-IORT
Number of subjects: 54

Group type: COMPARATOR
Intervention: Kypho-IORT and EBRT
Number of subjects: 54
Study: 27503746

Group type: EXPERIMENTAL
Intervention: Traditional needle acupuncture
Number of subjects: 116
Study: 26761967

Group type: EXPERIMENTAL
Intervention: Nicorandil in addition to standard therapy (aspirin, rosuvastatin, valsartan, bisoprolol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy (aspirin, rosuvastatin, valsartan, bisoprolol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-acting form of nitrates
Number of subjects: 0
Study: 23317561

Group type: EXPERIMENTAL
Intervention: Oral meprednisone preoperatively
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no preoperative systemic steroids)
Number of subjects: 54
Study: 22021510

Group type: EXPERIMENTAL
Intervention: Low-dose chest CT examination
Number of subjects: 26724

Group type: EXPERIMENTAL
Intervention: Low-dose chest CT examination (using ICRP 60 tissue-weighting factors)
Number of subjects: 26724

Group type: EXPERIMENTAL
Intervention: Low-dose chest CT examination (using ICRP 103 tissue-weighting factors)
Number of subjects: 26724
Study: 18835927

Group type: EXPERIMENTAL
Intervention: Fluoxetine (6-week administration)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (identical to fluoxetine)
Number of subjects: 18
Study: 17973988

Group type: EXPERIMENTAL
Intervention: Moderate exercise prior to fat ingestion
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-fat meal alone (control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pooled exercise and control data
Number of subjects: 8
Study: 15072173

Group type: EXPERIMENTAL
Intervention: Auto-titrating CPAP (APAP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fixed CPAP (F-CPAP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: F-CPAP
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: APAP
Number of subjects: 10
Study: 11278212

Group type: EXPERIMENTAL
Intervention: Low-dose step-up regimen (starting dose 75 IU)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Modified step-down regimen (starting dose 300 IU, followed by 3 days free of treatment, then 75 IU daily)
Number of subjects: 26
Study: 9042530

Group type: EXPERIMENTAL
Intervention: Dim Light‐Caffeine (200 mg twice each night)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bright Light‐Caffeine (> or = 2000 lux)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dim Light‐Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bright Light‐Placebo
Number of subjects: 0
Study: 7943687

Group type: EXPERIMENTAL
Intervention: Electroencephalographic beta-activity at the vertex lead
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Larger amplitude carotid pulse
Number of subjects: 31
Study: 3652755

Group type: EXPERIMENTAL
Intervention: Medical Graphics Corporation System 2000
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sensormedics MMC Horizon system
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Different methods of analyzing data
Number of subjects: 12
Study: 31461478

Group type: EXPERIMENTAL
Intervention: Long-term meditators (LTM)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Mindfulness-based stress reduction (MNP intervention)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Health enhancement program (MNP intervention)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Waitlist control group (MNP intervention)
Number of subjects: 99